Platelets selectively enhance lymphocyte adhesion on subendothelial matrix under arterial flow conditions

Thrombosis and Haemostasis

Volumn 108, Issue 2, 2012, Pages 328-337

  Spectre, Galia ^a,b   Zhu, Linjing ^a   Ersoy, Maria ^a   Hjemdahl, Paul ^a   Savion, Naphtali ^c   Varon, David ^b   Li, Nailin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Arterial flow; Lymphocytes; Platelets; Subendothelial matrix proteins

Indexed keywords

CD11B ANTIGEN; CD40 LIGAND; COLLAGEN; FIBRINOGEN; FIBRINOGEN RECEPTOR; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; B LYMPHOCYTE; CD4 CD8 RATIO; CELL ADHESION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEAR RATE; SUBENDOTHELIUM; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADULT; AGED; ARTERIES; BLOOD FLOW VELOCITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLLAGEN; ENDOTHELIAL CELLS; FEMALE; FIBRINOGEN; FIBRONECTINS; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; LYMPHOCYTES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PLATELET ADHESIVENESS; POLYSTYRENES; SERUM ALBUMIN, BOVINE; VON WILLEBRAND FACTOR;

EID: 84864374416     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-02-0064     Document Type: Article

References (32)

1. Huo Y, Schober A, Forlow SB, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61-67.
2. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357: 2482-2494.
3. Li N. Platelet lymphocyte cross-talk. J Leukoc Biol 2008; 83: 1069-1078.
4. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
5. Massberg S, Brand K, Gruner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196: 887-896.
6. Massberg S, Schurzinger K, Lorenz M, et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 2005; 112: 1180-1188.
7. Rinder HM, Bonan JL, Rinder CS, et al. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991; 78: 1730-1737.
8. Li N, Ji Q, Hjemdahl P. Platelet-lymphocyte conjugation differs between lymphocyte subpopulations. J Thromb Haemost 2006; 4: 874-881.
9. Diacovo TG, Puri KD, Warnock RA, et al. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 1996; 273: 252-255.
10. Lalor P, Nash GB. Adhesion of flowing leucocytes to immobilized platelets. Br J Haematol 1995; 89: 725-732.
11. Elzey BD, Tian J, Jensen RJ, et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 2003; 19: 9-19.
12. Gerdes N, Zhu L, Ersay M, et al. Platelets regulate CD4+ T cell differentiation via multiple chemokines in humans. Thromb Haemost 2011; 106: 353-362.
13. Elzey BD, Grant JF, Sinn HW, et al. Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. J Leukoc Biol 2005; 78: 80-84.
14. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378-3384.
15. Butler LM, Metson-Scott T, Felix J, et al. Sequential adhesion of platelets and leukocytes from flowing whole blood onto a collagen-coated surface: requirement for a GPVI-binding site in collagen. Thromb Haemost 2007; 97: 814-821.
16. He S, Cao H, Magnusson CG, et al. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein. Thromb Res 2001; 103: 241-248.
17. Varon D, Dardik R, Shenkman B, et al. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997; 85: 283-294.
18. Li N, Wallén NH, Hjemdahl P. Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation 1999; 100: 1374-1379.
19. Hu H, Li N, Yngen M, et al. Enhanced leukocyte-platelet cross-talk in type 1 diabetes mellitus: relationship to microangiopathy. J Thromb Haemost 2004; 2: 58-64.
20. Eriksson EE. Intravital microscopy on atherosclerosis in apolipoprotein e-deficient mice establishes microvessels as major entry pathways for leukocytes to advanced lesions. Circulation 2011; 124: 2129-2138.
21. Hu H, Zhu L, Huang Z, et al. Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus. Thromb Haemost 2010; 104: 1184-1192.
22. Skilbeck C, Westwood SM, Walker PG, et al. Population of the vessel wall by leukocytes binding to P-selectin in a model of disturbed arterial flow. Arterioscler Thromb Vasc Biol 2001; 21: 1294-1300.
23. Solpov A, Shenkman B, Vitkovsky Y, et al. Platelets enhance CD4+ lymphocyte adhesion to extracellular matrix under flow conditions: role of platelet aggregation, integrins, and non-integrin receptors. Thromb Haemost 2006; 95: 815-821.
24. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297.
25. Mou Y, Ni H, Wilkins JA. The selective inhibition of beta 1 and beta 7 integrin-mediated lymphocyte adhesion by bacitracin. J Immunol 1998; 161: 6323-6329.
26. Ni H. Unveiling the new face of fibronectin in thrombosis and hemostasis. J Thromb Haemost 2006; 4: 940-942.
27. Ni H, Yuen PS, Papalia JM, et al. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci USA 2003; 100: 2415-2419.
28. Beumer S, de Groot PG, et al. Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin. Blood 1994; 84: 3724-3733.
29. Cho J, Mosher DF. Enhancement of thrombogenesis by plasma fibronectin crosslinked to fibrin and assembled in platelet thrombi. Blood 2006; 107: 3555-3563.
30. Lievens D, Eijgelaar WJ, Biessen EA, et al. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost 2009; 102: 206-214.
31. André P, Prasad KS, Denis CV, et al. CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism. Nat Med 2002; 8: 247-252.
32. McCarty OJ, Zhao Y, Andrew N, et al. Evaluation of the role of platelet integrins in fibronectin-dependent spreading and adhesion. J Thromb Haemost 2004; 2: 1823-1833.